FDA NDC Directory · JSON-LD · Markdown
NDC 58118-1189 · HUMAN PRESCRIPTION DRUG · TABLET
| Labeler / Manufacturer | Clinical Solutions Wholesale, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA203326 |
| Dosage form / route | TABLET · SUBLINGUAL |
| Active ingredients | BUPRENORPHINE HYDROCHLORIDE (8 mg/1) NALOXONE HYDROCHLORIDE DIHYDRATE (2 mg/1) |
| Marketing started | 20140627 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).